2-Chloro-5-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95+%, 100mg

2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid, 95.0%, 5g

L-(+)-2-Amino-4-phosphonobutyric acid, >99%, 5mg

4-Methyl-1H-indole-2,3-dione, 95.0%, 250mg

GC capillary column ROTI®Cap-5, 60 m, 0.25 mm, 0.35 µm, 1 Piece(s)

4,7,10,13-Tetraoxa-16-azaoctadecanoic acid, 18-bromo-17-oxo-, 2,5-dioxo-1-pyrrolidinyl ester, 95%, 100mg

4-Methyl-2-nitrobenzaldehyde, 95.0%, 1g

(S)-2-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-phenylpropanamido)-3-phenylpropanoic acid, 95%, 25g

C-(3-Methoxy-phenyl)-C-phenyl-methylamine, 95.0%, 100mg

(E)-2-CYANO-3-(3,6-DICHLOROPYRIDIN-2-YL)-N-(1-(4-(2-MORPHOLINOETHOXY)PHENYL)BUTYL)ACRYLAMIDE, 95%, 100mg

2-Bromo-4-phenyl-nicotinic acid, 95.0%, 5g

Dodecyl isothiocyanate, 90%, 5g

Cyclamic acid (sodium), 1kg